WalkHome
Financiado
Functional Electrical Stimulation for at Home Rehabilitation
The Context
Stroke has huge human and economic cost. 1 million people suffer strokes in Europe every year, with an average life expectancy after stroke of 8 years. Roughly 20% of stroke survivors suffer from drop foot, with 45 bi...
The Context
Stroke has huge human and economic cost. 1 million people suffer strokes in Europe every year, with an average life expectancy after stroke of 8 years. Roughly 20% of stroke survivors suffer from drop foot, with 45 billion euros spent on rehabilitating stroke patients in Europe every year.
The opportunity:
FES offers the tantalising prospect of retraining voluntary motor functions such as walking. However:
- FES rehabilitation must be carried out in a hospital with the support of trained healthcare professionals;
- Transporting patients and supervising treatment is expensive;
- Patient’s treatment plan is sub-optimal;
- Per patient rehabilitation costs reach 32,000 euros
Our solution:
Fesia WalkHome is a FES rehabilitation device for drop foot patients which can be administered by the patient in their own home. This not only reduces costs by 43% but also means patients can have an optimal treatment plan, improving their speed of recovery.
The use of Fesia Walk at home will give autonomy, independence and improve the quality of life for chronic patients. It will also mean a substantial reduction of waiting lists, health costs, number of physician office visits, and carer support.
The Project:
WalkHome represents a disruptive change of paradigm for the FES rehabilitation standard of care. The aim of the phase 1 project is to improve our understanding of the EU market for FES rehabilitation, identifying regional market variations in terms of key decision makers, appropriate business models, pricing structure and identifying which are the most attractive markets for us to use as a beachhead. We will also analyse what key improvements need to be made to the existing technology to create the new FES home care rehabilitation market.
The Market:
Currently, there is no FES rehabilitation technology that is offered outside of a clinical setting. We estimate that this new home FES rehabilitation market could be worth up to 40 billion euros in Europe alone.
ver más
Duración del proyecto: 4 meses
Fecha Inicio: 2018-05-04
Fecha Fin: 2018-09-30
Fecha Fin: 2018-09-30
Línea de financiación: concedida
El organismo H2020 notifico la concesión del proyecto el día 2018-09-30
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
EIC-SMEInst-2018-2020:
SME instrument
Cerrada
hace 6 años
Presupuesto
El presupuesto total del proyecto asciende a
71K€
Líder del proyecto
FESIA TECHNOLOGY
El desarrollo y comercialización de dispositivos terapéuticos de estimulación eléctrica funcional para personas con afecciones neurológicas...
Perfil tecnológico
TRL
4-5
130K
Perfil tecnológico
TRL
4-5
130K